The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price for chloroquine and the retail prices for 62 pharmaceutical formulations. These prices are exclusive of Goods and Services Tax, if applicable. These prices were notified on September 10, 2024.
Revised Ceiling Price for Chloroquine
It may be recalled that by an order dated March 26, 2024, NPPA had specified revisions in ceiling prices of several medicines through. These medicines included Chloroquine in the form of tablet and oral liquid. The order specified that 1 Tablet of Chloroquine 150 mg would have a ceiling price of Rs. 1.17 and 1 ml of Oral liquid Chloroquine 50mg/5mL would have a ceiling price of Rs. 0.34.
Now by the present order the NPPA has further increased the ceiling price of 1 Tablet of Chloroquine 150 mg. This revision is as follows:
Dosage form & Strength | Dosage form & Strength | Unit | Ceiling Price under NLEM, 2022 (Rs.) | Revised Ceiling price based on Review Order & considering WPI @0.00551% (Rs.) |
|---|---|---|---|---|
| Chloroquine | Tablet 150 mg | 1 Tablet | 1.17 | 1.33 |
The new prices take into account a minimal increase based on the Wholesale Price Index (WPI).
All manufacturers selling the branded or generic or both the versions of this formulation at a price higher than the ceiling price (plus Goods and Services Tax as applicable) shall revise the prices of all such formulations downward not exceeding the ceiling price.
Existing manufacturers of above-mentioned scheduled formulations having MRP lower than the ceiling price shall continue to maintain the existing MRP.
Manufactures must issue a price list in Form–V from date of Notification through IPDMS and submit a copy to State Drug Controller and dealers. Additionally, manufacturers shall also furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS.
Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish
information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013. This information shall be furnished at least six months prior to the intended date of discontinuation.
All retailers and dealers must display price list and the supplementary price list furnished by the manufacturer on a conspicuous part of the premises where he carries on business.
Manufactures that do not comply with the ceiling price and other stipulations will be liable to deposit the
overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
